Fler resultat...
Biotech company Alligator Bioscience AB interviews PALEMA in its annual report for 2025 and discusses, among other things, Emergency cancer (Blåljuscancer), medical needs, clinical studies and what message PALEMA wants to send to decision-makers and healthcare.
This exciting step forward follows a two-year clinical trial, in which researchers at Imperial College London analyzed over 700 breath samples from people with and without pancreatic cancer, as well as from people with other conditions affecting the pancreas.
An 18th century remedy could be a new weapon in the fight against one of the most deadly cancers. Researchers in Skövde, Sweden, together with Skaraborg Hospital, are now starting a clinical trial to investigate whether the heart medicine digitoxin, originally extracted from the foxglove flower, can be used against pancreatic cancer.
Pancreatic cancer is one of the most aggressive cancers. A new study from Karolinska Institutet in collaboration with the Department of Pathology at Karolinska University Hospital shows that tumor cells grow not only in the connective tissue-rich environment typical of the disease, but also in damaged parts of the pancreas where normal tissue has been altered. The findings may provide new insights into tumor development and treatment.
A new study from Karolinska Institutet, published in the scientific journal The BMJ, shows that a simple blood test can predict the risk of developing serious liver disease. The method could be used in primary care already now and contribute to earlier detection of cirrhosis and liver cancer.
The Swedish cancer association PALEMA is awarding its research grants for the first time to two promising young cancer researchers in the field of liver and biliary tract cancer. This year’s recipients are **Anna Forslund**, specialist surgeon at Sahlgrenska University Hospital, and **Antonio Akiki**, junior doctor at the Upper Abdominal Disease Unit, Karolinska University Hospital.
Until now, PALEMA’s project grants for cancer researchers have been awarded in the field of pancreatic cancer. This year, for the first time, they are also being awarded in the areas of esophageal and gastric cancer. The 2025 project grants are awarded to Elina Azizi, PhD candidate at CLINTEC, Karolinska Institutet, and Cecilia Ringborg, postdoctoral researcher at Karolinska Institutet.
Pancreatic cancer is one of the most difficult cancers to treat, but several promising studies presented at ASCO 2025 show progress in locally advanced, resectable and metastatic disease.
Exercise should be an integral part of the care plan for cancer patients - for real. Not as a parenthesis in a brochure, but as a prescription, with the same weight as chemotherapy or blood pressure medication, writes Ulf Bengtsson, wellness entrepreneur, inspirer and founder of WorldClass and Stand Up Stay Strong.
Pancreatic cancer strikes quickly and mercilessly. Luciano Pavarotti, Ruth Bader Ginsburg, Sven-Göran Eriksson, Johannes Brost. The names are many, the fates tragic. The diagnosis is a death sentence. But now there is hope.
One of the pioneers of research that could lead to the development of customised vaccines for cancer treatment is Catherine J. Wu of the Dana-Farber Cancer Institute in Boston, USA. She is now awarded the Sjöberg Prize of one million US dollars for her efforts.
What does quality of life really mean? Researchers at Lund University analysed 356 different health factors in almost 30 000 men and women aged 50-64. Using AI, they were able to rank all the different variables and come up with a top five list.
An international research study has shown that pancreatic cancer cells are able to alter the fuel they use to grow and spread to help them survive in difficult environments, a finding that scientists hope could be exploited to develop new treatments for pancreatic cancer.
Extensive research has shown the negative health effects of excessive sugar intake, leading to recommendations to limit the consumption of "free" or added sugar to less than 10% of total calorie intake per day.
An artificial intelligence tool has successfully identified people at the highest risk for pancreatic cancer up to three years before diagnosis using solely the patients’ medical records.
